XENON PHARMACEUTICALS INC. Lessee, Operating Lease, Liability, to be Paid, Year One
XENON PHARMACEUTICALS INC. (XENE) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.14 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.14M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.77M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.80M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.80M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $1.14M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.77M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.80M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.80M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $1.81M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $1.75M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.69M 10-K · filed 2025-02-27 |
| 2024-09-30 | $1.75M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.74M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.75M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.70M 10-K · filed 2024-02-29 |
| 2023-09-30 | $1.68M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.70M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.68M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.62M 10-K · filed 2023-03-01 |
| 2022-09-30 | $852.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $915.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $942.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $879.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | $697.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $713.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $703.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $811.00K 10-K · filed 2021-03-01 |
| 2020-09-30 | $599.00K 10-Q · filed 2020-11-05 |
| 2019-12-31 | $650.00K 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |